Drug Drug Interactions

Drug-Drug Interaction assessment is an essential component of the drug discovery process and the clinical development process, especially in cases where patients are prescribed multiple drugs. Many CRO Providers provide expertise in evaluation of Phase I and Phase II Drug Metabolism drug-drug interactions by measuring potential cytotoxic effects from the actions of several key enzymes.
If you have a question about drug drug interaction studies, click on the orange Request button on the right side of the page to request information from one or more expert CROs.
Scroll down to browse services for Phase I Drug Metabolism Toxicity studies, including CYP450, AhR and PXR assays, and Phase II Drug Metabolism Toxicity studies, including glucuronides, UDP-glucuronsyltransferases, and sulfotransferases assays.
Use the filters on the left to refine the list and then click on any listing to view technical information or to ask a question. Click on the Vendors tab to view a complete list of CROs that offer drug drug interaction models.
Ask An Expert
Use our free service locator program to find the research services you need.Search PubMed
Search PubMed for "Drug-Drug Interactions" using BioWizard.- Below is a list of services and products in this research area.
- Use the filters on the left to refine the list.
- Click on any listing to get technical information or to ask a question.
- Click on the Vendors tab to find vendors that offer Drug-Drug Interactions Services.










